C-MER Eye Care Holdings Limited
Symbol: 3309.HK
HKSE
3.11
HKDMarket price today
62.7191
P/E Ratio
0.0000
PEG Ratio
3.87B
MRK Cap
- 0.00%
DIV Yield
C-MER Eye Care Holdings Limited (3309-HK) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 557.4 | 698.5 | 442.4 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 44.7 | 53.8 | 55.7 | ||||||||||
balance-sheet.row.net-receivables | 0 | 66.7 | 53.9 | 30.1 | ||||||||||
balance-sheet.row.inventory | 0 | 42 | 55.6 | 34.5 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 54.1 | 48.6 | 239.5 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 720.1 | 856.6 | 746.4 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1000.3 | 1057.6 | 901.3 | ||||||||||
balance-sheet.row.goodwill | 0 | 530.4 | 540.7 | 195 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 558.2 | 821.4 | 204 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1088.6 | 1362.1 | 398.9 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 193.1 | 129.2 | 77.4 | ||||||||||
balance-sheet.row.tax-assets | 0 | 6.8 | 6.9 | 11 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | -260.3 | -510.7 | -179.1 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2028.5 | 2045.1 | 1209.5 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.account-payables | 0 | 54.9 | 45.3 | 39.9 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 116.5 | 149.3 | 265.5 | ||||||||||
balance-sheet.row.tax-payables | 0 | 24 | 18.9 | 8.5 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 13.8 | 21.2 | 7.6 | ||||||||||
Deferred Revenue Non Current | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 163.7 | 290.7 | 92.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 366 | 378.6 | 210.4 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.total-liab | 0 | 755.3 | 903.4 | 618.6 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 1520.5 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 125.6 | 126.7 | 115 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 77.4 | 26.6 | 50.5 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -3.1 | 9.6 | 79 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 125.6 | 1703.2 | 1086.7 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1845.8 | 1866.1 | 1331.2 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 147.5 | 132.2 | 6 | ||||||||||
balance-sheet.row.total-equity | 0 | 1993.3 | 1998.2 | 1337.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 237.7 | 183 | 133.1 | ||||||||||
balance-sheet.row.total-debt | 0 | 363 | 452.5 | 471.7 | ||||||||||
balance-sheet.row.net-debt | 0 | -149.8 | -192.2 | 85 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 62 | -21.9 | 21.9 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 223.7 | 148.6 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -483.2 | -309.4 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 1.3 | 4.3 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -32.7 | -7.4 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -26.7 | -18.5 | ||||||||||
cash-flows.row.inventory | 0 | 0 | -8.7 | -9.2 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 0.9 | 19.7 | ||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 1.7 | 0.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -62.1 | 504.6 | 290.6 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | -80.3 | -223.5 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -39.2 | -40 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 106.7 | 277.6 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -106.7 | -277.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -210.7 | -392.7 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -162 | -174.4 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 607.7 | 9.2 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -29.9 | -88.6 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -132.9 | -23 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -1.2 | 354.9 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 281.6 | 78.1 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -4.8 | -1.1 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 258 | -167.3 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 644.7 | 644.7 | 386.7 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 644.7 | 386.7 | 553.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 191.9 | 148.4 | ||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 100.6 | 19.2 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1924 | 1731.9 | 1112.6 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1381.5 | 1366.6 | 803.1 | ||||||||||
income-statement-row.row.gross-profit | 0 | 542.5 | 365.3 | 309.4 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 426 | 389.8 | 311.8 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1807.5 | 1756.3 | 1114.9 | ||||||||||
income-statement-row.row.interest-income | 0 | 19.9 | 7.1 | 4.5 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 220.7 | 223.7 | 148.6 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 116.4 | -24.4 | -2.3 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 121.1 | -49 | 16.2 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 37.9 | 35 | 10.6 | ||||||||||
income-statement-row.row.net-income | 0 | 62 | -21.9 | 21.9 |
Frequently Asked Question
What is C-MER Eye Care Holdings Limited (3309.HK) total assets?
C-MER Eye Care Holdings Limited (3309.HK) total assets is 2748635000.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.282.
What is company free cash flow?
The free cash flow is 0.215.
What is enterprise net profit margin?
The net profit margin is 0.032.
What is firm total revenue?
The total revenue is 0.060.
What is C-MER Eye Care Holdings Limited (3309.HK) net profit (net income)?
The net profit (net income) is 61998000.000.
What is firm total debt?
The total debt is 362990000.000.
What is operating expences number?
The operating expences are 426032000.000.
What is company cash figure?
Enretprise cash is 0.000.